Arbutus Biopharma Competitors and Similar CompaniesClear all
Arbutus Biopharma's competitors and similar companies include Rani Therapeutics, CSL Behring, Chiesi Group and Livzon Pharmaceutical Group.
 Arbutus Biopharma Arbutus Biopharma is a clinical-stage biopharmaceutical company that focuses on virology. |  Rani Therapeutics Rani Therapeutics Holdings is a clinical-stage biotherapeutics company developing technologies for orally administered biologics. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2005 | Founding Date 2012 | Founding Date 1904 | Founding Date 1935 | Founding Date 1985 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Warminster, US HQ | Locations San Jose, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 1957% decrease | Employees 71 | Employees 7,5692% decrease | Employees 5,8541% increase | Employees 9,067 |
Valuation ($) | Valuation ($) 762.7 m | Valuation ($) 135.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $14.1m (FY, 2025) | Revenue (est.) $1.6m (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) ¥11.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income ($33.5m) (FY, 2025) | Net income ($41m) (FY, 2025) | Net income N/A | Net income N/A | Net income ¥2.4b (FY, 2025) |
Operating ⚠ | |||||
Trademark Applications | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications 1 (Dec, 2020) | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks 4 (Dec, 2020) | Trademarks N/A | Trademarks 45 (Sep, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Rani Therapeutics
HQ
San Jose, US
Employees
71
Rani Therapeutics Holdings is a clinical-stage biotherapeutics company developing technologies for orally administered biologics.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company